|
|
||||||||||||||
|
|
|||||||||||||||
MUTATION REPORT |
1 Unit of Molecular Neurogenetics, Pierfranco and Luisa Mariani Center for the Study of Mitochondrial Disorders in Children, RCCS Foundation Neurological Institute C. Besta, Milan, Italy
2 Unit of Biochemistry and Genetics, IRCCS Foundation Neurological Institute C. Besta, Milan, Italy
3 Division of Metabolic Disorders, Department of Pediatrics, University Hospital, Padova, Italy
4 Klinik für Neuropädiatrie, Behandlungszentrum Vogtareuth, Germany
5 Unit of Child Neurology, IRCCS Foundation Neurological Institute C. Besta, Milan, Italy
6 Division of Pediatric Genetics and Metabolism University of Florida, USA
7 Centre for Inherited Metabolic Diseases, Karolinska University, Stockholm, Sweden
8 Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan and Department of Chemistry, University of Sassari, Sassari Italy
Correspondence to:
Dr V Tiranti, Unit of Molecular Neurogenetics, IRCCS Foundation Neurological Institute C. Besta, Via Temolo, 4, 20126 Milan, Italy; tiranti{at}istituto-besta.it]
Background: Ethylmalonic encephalopathy (EE) is a rare autosomal recessive metabolic disorder characterised by progressive encephalopathy, recurrent petechiae, acrocyanosis and chronic diarrhoea, with a fatal outcome in early in life.
Methods: 14 patients with EE were investigated for mutations in the ETHE1 gene.
Results: Of the 14 patients, 5 were found to carry novel mutations.
Conclusions: This work expands our knowledge of the causative mutations of EE.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |